NCT06094478 Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
| NCT ID | NCT06094478 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Stroke, Acute |
| Study Type | INTERVENTIONAL |
| Enrollment | 900 participants |
| Start Date | 2024-10-17 |
| Primary Completion | 2028-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 900 participants in total. It began in 2024-10-17 with a primary completion date of 2028-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments. This study will help hospitals across the US "stand up" new ways to evaluate stroke patients, decide who needs to be transferred, and transfer them quickly for advanced treatment.
Eligibility Criteria
Inclusion Criteria: * Age \>=18 years * Final diagnosis: AIS, ICH, or SAH Exclusion Criteria: * Final diagnosis: TIA or stroke NOS * Age \<18 years * Comfort care measures on day 0 or 1 * Left hospital against medical advice * Enrolled in clinical trial related to stroke that is competing with this study
Frequently Asked Questions
Who can join the NCT06094478 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06094478 currently recruiting?
Yes, NCT06094478 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Chicago to inquire about joining.
Where is the NCT06094478 trial being conducted?
This trial is being conducted at New Haven, United States, Miami, United States, Atlanta, United States, Chicago, United States and 1 additional location.
Who is sponsoring the NCT06094478 clinical trial?
NCT06094478 is sponsored by University of Chicago. The trial plans to enroll 900 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.